<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-06T17:27:13+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>51款注射剂厉害！正大天晴、恒瑞、齐鲁领跑过评榜，一致性评价、集采冲击6000亿市场</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/5xFL4hno-LhpExA6ztS-sQ</id>
    <link href="https://mp.weixin.qq.com/s/5xFL4hno-LhpExA6ztS-sQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【市场】100亿级重磅品种，这家江苏药企拿下</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/A6RYdiuNUI3n8SWbm6esgw</id>
    <link href="https://mp.weixin.qq.com/s/A6RYdiuNUI3n8SWbm6esgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】4亿抗生素大品种，国产第3家将诞生</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/cvnngZO9g6oEnYVThISPNA</id>
    <link href="https://mp.weixin.qq.com/s/cvnngZO9g6oEnYVThISPNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】这家眼科用药龙头，滴眼剂新品来袭</title>
    <updated>2020-11-06T16:08:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/il-4K0KENMJChWant4hjkQ</id>
    <link href="https://mp.weixin.qq.com/s/il-4K0KENMJChWant4hjkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥赛康首个PPI注射剂过评！挑战“万能靶向药”，1类新药、首仿……迎爆发期</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/XpNe-O-MoAT4yF_k98lUFA</id>
    <link href="https://mp.weixin.qq.com/s/XpNe-O-MoAT4yF_k98lUFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】四川药企猛攻吸入剂！入局10亿品种，3大吸入剂抢首仿</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/mgQh3xuwiLFZDvfoaRu47g</id>
    <link href="https://mp.weixin.qq.com/s/mgQh3xuwiLFZDvfoaRu47g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】成都药企爆发了！拿下重磅注射剂，2大新品将获批</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/6e_CzwoX3WfScvV-DeHayg</id>
    <link href="https://mp.weixin.qq.com/s/6e_CzwoX3WfScvV-DeHayg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【聚焦】汇宇制药又有新品来袭，今年第5个注射剂报产</title>
    <updated>2020-11-05T15:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/S9RfUC-vAwC4ESJajgtW9g</id>
    <link href="https://mp.weixin.qq.com/s/S9RfUC-vAwC4ESJajgtW9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>344家药企三季报出炉！40家亏损，迈瑞、恒瑞……净利润超40亿，16家毛利率超90%</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/SnRqlJ3sBYSjvf5RxPGrvw</id>
    <link href="https://mp.weixin.qq.com/s/SnRqlJ3sBYSjvf5RxPGrvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【热点】NEXT主旨演讲人和直播抽奖揭晓！立即注册NEXT CHINA 2020</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/FqUUvIfINs7yr03pGyWrGA</id>
    <link href="https://mp.weixin.qq.com/s/FqUUvIfINs7yr03pGyWrGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】2亿抗肿瘤药“激战”！正大天晴、齐鲁、石药8家药企抢首仿</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/GHHCEPM0h4G6XEAuPGO8Ww</id>
    <link href="https://mp.weixin.qq.com/s/GHHCEPM0h4G6XEAuPGO8Ww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】阿斯利康超10亿吸入剂告急？石四药、健康元等蜂拥而至</title>
    <updated>2020-11-04T16:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/aptm5_w7lfXfJJxvCO5F-A</id>
    <link href="https://mp.weixin.qq.com/s/aptm5_w7lfXfJJxvCO5F-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3000亿市场增速持续下滑，专业化落地成连锁药店进阶重点</title>
    <updated>2020-11-03T15:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/WeAwBUOrzAsp8cThHmhntg</id>
    <link href="https://mp.weixin.qq.com/s/WeAwBUOrzAsp8cThHmhntg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【现场】刚刚！第14站米房会•江西理事会成立</title>
    <updated>2020-11-03T15:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/bxZbBV0KJZF7vlUSXHLBSw</id>
    <link href="https://mp.weixin.qq.com/s/bxZbBV0KJZF7vlUSXHLBSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【焦点】丽珠半壁江山不保！明星品种首家过评被湖南药企拿下</title>
    <updated>2020-11-03T15:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/2LZe2Z9ZnUv7IsLV-upr0w</id>
    <link href="https://mp.weixin.qq.com/s/2LZe2Z9ZnUv7IsLV-upr0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>5752亿元！2020H1中国公立医疗机构终端药品销售额下降13.9%，创新药迎来黄金期</title>
    <updated>2020-11-02T17:29:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/gyvwngAZtM6UDAVWBuSSrQ</id>
    <link href="https://mp.weixin.qq.com/s/gyvwngAZtM6UDAVWBuSSrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】厉害了！药企3款注射剂齐过评，$25亿品种首仿将拿下</title>
    <updated>2020-11-02T17:29:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/YTXats_50ZF4-PKUmZtRKw</id>
    <link href="https://mp.weixin.qq.com/s/YTXats_50ZF4-PKUmZtRKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】东阳光药将拿下15亿抗血栓药</title>
    <updated>2020-11-02T17:29:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/m4U-ciCIx3fIhkOhqjFUew</id>
    <link href="https://mp.weixin.qq.com/s/m4U-ciCIx3fIhkOhqjFUew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【市场】15亿降血脂药！华润双鹤过评了</title>
    <updated>2020-11-02T17:29:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/HT_U5NLA1Ye41H9qEkocLw</id>
    <link href="https://mp.weixin.qq.com/s/HT_U5NLA1Ye41H9qEkocLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10月CDE：12个品种首家企业开始一致性评价；2个重磅1类新药报产；3个首仿品种获批</title>
    <updated>2020-11-01T08:09:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/ZVTjvbGwJlQBi2KVEQSxfg</id>
    <link href="https://mp.weixin.qq.com/s/ZVTjvbGwJlQBi2KVEQSxfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>